Cargando…
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
BACKGROUND: Lung cancer is the leading cause of the largest number of deaths worldwide and lung adenocarcinoma is the most common form of lung cancer. In order to understand the molecular basis of lung adenocarcinoma, integrative analysis have been performed by using genomics, transcriptomics, epige...
Autores principales: | Zengin, Talip, Önal-Süzek, Tuğba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526001/ https://www.ncbi.nlm.nih.gov/pubmed/32998690 http://dx.doi.org/10.1186/s12859-020-03691-3 |
Ejemplares similares
-
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Zengin, Talip, et al.
Publicado: (2021) -
Tissue Microbiome Associated With Human Diseases by Whole Transcriptome Sequencing and 16S Metagenomics
por: Salihoğlu, Rana, et al.
Publicado: (2021) -
Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma
por: Ye, Jing, et al.
Publicado: (2019) -
Extracellular Matrix Protein 1 Gene Mutation in Turkish Patients with Lipoid Proteinosis
por: Dertlioğlu, Selma Bakar, et al.
Publicado: (2019) -
An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)